584
Views
9
CrossRef citations to date
0
Altmetric
Applications and Case Studies

Optimal Allocation of Gold Standard Testing Under Constrained Availability: Application to Assessment of HIV Treatment Failure

, , , &
Pages 1173-1188 | Received 01 Jan 2012, Published online: 19 Dec 2013
 

Abstract

The World Health Organization (WHO) guidelines for monitoring the effectiveness of human immunodeficiency virus (HIV) treatment in resource-limited settings are mostly based on clinical and immunological markers (e.g., CD4 cell counts). Recent research indicates that the guidelines are inadequate and can result in high error rates. Viral load (VL) is considered the “gold standard,” yet its widespread use is limited by cost and infrastructure. In this article, we propose a diagnostic algorithm that uses information from routinely collected clinical and immunological markers to guide a selective use of VL testing for diagnosing HIV treatment failure, under the assumption that VL testing is available only at a certain portion of patient visits. Our algorithm identifies the patient subpopulation, such that the use of limited VL testing on them minimizes a predefined risk (e.g., misdiagnosis error rate). Diagnostic properties of our proposed algorithm are assessed by simulations. For illustration, data from the Miriam Hospital Immunology Clinic (Providence, RI) are analyzed.

Acknowledgments

This research is funded by a 2009 developmental grant from the Lifespan/Tufts/Brown Center for AIDS Research. The project described is supported by grant number P30AI042853 from the National Institute of Allergy and Infectious Diseases (NIAID). The work of Dr. Kantor is also supported by a grant (number R01AI66922) from the National Institute of Health (NIH). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIAID or NIH. The authors are grateful for the helpful comments from reviewers, the associate editor, and the editor. The authors also thank Ms. Allison K. DeLong for discussions and comments on early versions of the article.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.